PharmaShots | Incisive News in 3 Shots

Subscribe Now

Discontinues

AB Science Holds the Clinical Studies of Masitinib Globally

AB Science Holds the Clinical Studies of Masitinib Globally

June 1, 2021

GSK Discontinues the P-II Trials of Feladilimab for Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

GSK Discontinues the P-II Trials of Feladilimab for Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

April 16, 2021

Spring Bank Discontinues the Development of Inarigivir to Treat Patients with Chronic Hepatitis B Virus

Spring Bank Discontinues the Development of Inarigivir to Treat Patients with Chronic Hepatitis B Virus

January 30, 2020

Teva Discontinues its P-III ENFORCE Study of Fremanezumab for Episodic Cluster Headache

Teva Discontinues its P-III ENFORCE Study of Fremanezumab for Episodic Cluster Headache

April 24, 2019

Roche Discontinues P-III CREAD-1 and 2 Trials of Crenezumab in Patients with Early Alzheimer's Disease (AD)

Roche Discontinues P-III CREAD-1 and 2 Trials of Crenezumab in Patients with Early Alzheimer's Disease (AD)

January 31, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us